Vietnamese (HOSE) Pharma Industry Analysis
- 7D-2.0%
- 3M2.2%
- 1Y7.7%
- YTD-4.1%
Over the last 7 days, the Pharma industry has dropped 2.0%, driven by a pullback from DHG Pharmaceutical of 3.7%. This takes the industry's 12 month performance to a gain of 7.7%.
Industry Valuation and Performance
Has the Vietnamese Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Mon, 24 Jan 2022 | â‚«41.2t | â‚«17.9t | â‚«2.2t | 15.9x |
| Wed, 22 Dec 2021 | â‚«45.4t | â‚«18.8t | â‚«2.3t | 16.9x |
| Fri, 19 Nov 2021 | â‚«41.4t | â‚«18.7t | â‚«2.3t | 16.9x |
| Sun, 17 Oct 2021 | â‚«40.6t | â‚«18.7t | â‚«2.3t | 16.1x |
| Tue, 14 Sep 2021 | â‚«41.1t | â‚«18.7t | â‚«2.3t | 16.3x |
| Thu, 12 Aug 2021 | â‚«39.0t | â‚«18.7t | â‚«2.3t | 14.4x |
| Mon, 07 Jun 2021 | â‚«38.7t | â‚«18.1t | â‚«2.2t | 15.6x |
| Sun, 28 Feb 2021 | â‚«38.2t | â‚«18.0t | â‚«2.2t | 15.8x |
| Wed, 02 Dec 2020 | â‚«36.0t | â‚«17.8t | â‚«2.2t | 14.4x |
| Sat, 05 Sep 2020 | â‚«34.8t | â‚«18.0t | â‚«2.1t | 15.1x |
| Tue, 09 Jun 2020 | â‚«32.3t | â‚«18.6t | â‚«2.1t | 13.3x |
| Mon, 02 Mar 2020 | â‚«32.3t | â‚«18.1t | â‚«2.0t | 13.7x |
| Thu, 05 Dec 2019 | â‚«32.7t | â‚«17.6t | â‚«1.9t | 12.8x |
| Sun, 08 Sep 2019 | â‚«32.0t | â‚«17.5t | â‚«1.8t | 15x |
| Sat, 01 Jun 2019 | â‚«34.0t | â‚«17.2t | â‚«1.8t | 14.6x |
| Tue, 05 Mar 2019 | â‚«34.6t | â‚«17.5t | â‚«1.8t | 14.2x |
13.8x
Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 14.8x. It appears they believe that earnings will grow in-line with historical growth rates.
Past Earnings Growth: The earnings for companies in the Pharmaceuticals industry have grown 6.8% per year over the last three years, while revenues have remained mostly flat. This means that companies overall are more efficiently conducting business since profits are increasing while sales have been flat.
Industry Trends
Which industries have driven the changes within the Vietnamese Pharma industry?
| Pharma | -1.97% | |
Industry PE: Investors are most optimistic about the Pharma industry, which is trading close to its 3-year average PE ratio of 14.8x. This is likely because analysts are expecting annual earnings growth of 19%, which is higher than its past year's earnings growth of 5.7% per year.
Forecasted Growth: Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 19% over the next 5 years. This is better than it's past earnings growth rate of 5.7% per year.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| IMP Imexpharm | â‚«76.50k | 0.3% +â‚«13.3b | 33.0% | PE29.4x | |
| DHT Ha Tay Pharmaceutical JSC | â‚«43.30k | 0.7% +â‚«7.9b | -20.8% | PE15.8x |